Eris Bame is a Scientist in the department of Development Biomarkers at Biogen. His role encompasses the identification and development of biomarkers supporting clinical programs aligned with Biogen’s Multiple Sclerosis franchise as well as supporting the bioanalytical aspects of pharmacokinetic and immunogenicity strategy and assay development for large molecule therapeutics. He has a special interest in flow cytometry and the use of the technology in clinical settings for the purpose of identification and development of novel biomarkers.
Wednesday, November 6
3:30 PM – 3:45 PM